The use of comet assay to assess global DNA methylation in human biomonitoring studies by Costa, Carla et al.
ICAW 2015 
1-4 SEPTEMBER
ANTWERP, BELGIUM
CONFERENCE GUIDE
11th InternatIonal Comet assay Workshop
antWerp UnIversIty, BelgIUm
ICAW 2015
Conference Guide
11th International Comet Assay Workshop 85
P-13: The use of comet assay to assess global DNA methylation in human bio-
monitoring studies.
Carla Costa1, 2, Ana Catarina Alves3, Solange Costa1, 2, Amadeu M.V.M. Soares3, Marta S. Mon-
teiro3, Susana Loureiro3 and João Paulo Teixeira1, 2*
1Portuguese National Institute of Health, Portugal 
2EPIUnit - Institute of Public Health, University of Porto, Portugal 
3Department of Biology & CESAM, University of Aveiro, Portugal
The Comet assay is a valuable tool for the detection of DNA damage in genotox-
icity and human biomonitoring studies. Throughout the years, this biomarker has 
undergone several adaptations in their protocol in order to increase its sensitivity 
and the possible outcomes. By including an additional step of DNA digestion with le-
sion-specific endonucleases, the comet assay can provide information regarding the 
type of DNA damage detected in cells. The use of these enzymes has also allowed 
the development of a methylation-sensitive modified version of the comet assay. 
This version enables the routine measurement of global methylation, as well as CpG 
island DNA methylation in a variety of cells while simultaneously determining the 
genetic integrity of examined cells (Wentzel, 2012). Briefly, it makes use of isochi-
zomeric restriction enzymes HpaII and MspI (that display differential sensitivity to 
DNA methylation) to characterize methylation outside CpG islands and restriction 
enzyme NotI to determine DNA methylation in CpG islands. The technique has been 
recently adapted to a medium-throughput version (Lewies, 2014) that allows the 
simultaneous analysis of a larger number of samples and overcomes some techni-
cal problems. Nevertheless, this technique has not yet been carried out in human 
biomonitoring studies. In this context, the aim of this work was to make use of this 
version of the comet assay to characterize global DNA methylation in approximately 
50 human samples. Samples were analysed by the methylation-sensitive modified 
version of the comet assay (medium-throughput) and by ELISA based assay. Data 
obtained with both methods were compared and reproducibility of the methyla-
tion-sensitive modified version of the comet assay determined. Results obtained 
contribute to knowledge on the feasibility of this version of the comet assay and its 
possible usage in human biomonitoring studies as an epigenetic biomarker. 
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